Boothbay Fund Management’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Sell
102,793
-54,324
-35% -$1.64M 0.05% 455
2026
Q1
$4.44M Hold
157,117
– – 0.06% 351
2025
Q4
$4.36M Buy
157,117
+21,936
+16% +$528K 0.07% 332
2025
Q3
$3.37M Buy
135,181
+118,994
+735% +$2.64M 0.05% 429
2025
Q2
$285K Buy
+16,187
New +$261K 0.01% 1123

Other funds holding PHVS

Boothbay Fund Management's PHVS Position: Q2 2026 in Review

Boothbay Fund Management reduced its Pharvaris (PHVS) stake by 35% in Q2 2026, selling an estimated $1.64M and leaving 102,793 shares worth $3.55M. The position accounts for 0.05% of the portfolio, ranked #455.

Boothbay Fund Management first reported a position in PHVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.44M in Q1 2026. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Boothbay Fund Management held 102,793 shares of Pharvaris worth $3.55M as of Q2 2026.
  • Boothbay Fund Management sold 54,324 Pharvaris shares in Q2 2026, an estimated $1.64M.
  • Pharvaris made up 0.05% of Boothbay Fund Management's portfolio in Q2 2026, its #455 holding.
  • Boothbay Fund Management first reported a position in Pharvaris in Q2 2025 and has held it in 5 quarters since.
  • Boothbay Fund Management's Pharvaris position peaked at $4.44M in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.